Multicenter, international, retrospective study of prognostic factors for Ra223

Multicenter, international, retrospective study of prognostic factors for Ra223

Abstract The risk factors for adium-233 dichloride (Ra223) treatment on prognosis remain unclear.　We aimed to validate the risk model for a radium-233 dichloride (Ra223) on the prognosis of patients with metastatic castration-resistant prostate cancer (mCRPC). We retrospectively evaluated 345 patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Takuya Oishi, Hao-Lun Luo, Yoshiomi Hatayama, Hideo Kawaguchi, Daichi Sasaki, Ryuma Tanaka, Noriaki Ishii, Jotaro Mikami, Teppei Okamoto, Hayato Yamamoto, Masahiko Aoki, Yu-Li Su, Yen-Hao Chen, Yen-Hsiang Chang, Yen-Ta Chen, Hung-Jen Wang, Chikara Ohyama, Shingo Hatakeyama
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Scientific Reports
Subjects:
Metastatic
Castration-resistant
Prostate cancer
Radium-223
Risk factor
Survival
Online Access:https://doi.org/10.1038/s41598-025-95844-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-95844-8

Similar Items